Human RelA/NFkB p65 PharmaGenie ELISA Kit (SBRS1037)

Quantify RelA (NFkB p65) protein levels with this in vitro ELISA kit from Assay Genie, supporting research into inflammatory signaling cascades, immune response regulation, and oncogenic pathway analysis. The NFkB family of transcription factors orchestrates cytokine-driven gene expression, and the p65/RelA subunit is the most extensively characterized member, commonly examined in studies of NFkB activation dynamics, IκBα degradation kinetics, and nuclear translocation events following cellular stimulation. The kit accommodates multiple human sample preparations, including cultured cell supernatant, blood-derived plasma fractions, and serum fractions, making it well matched for pathway-focused investigations in oncology, immunology, inflammation biology, and signal transduction laboratories. Packaged in a 96-assay configuration, the reagents support replicate measurements across treated and untreated cohorts, time-course experiments, and dose-response studies. Researchers profiling transcription factor activity, drug response phenotypes, or inflammatory disease models can use this assay to compare p65 levels between stimulated and resting conditions, track pathway inhibition kinetics, or stratify samples by signaling status.